BNGO
Bionano Genomics Inc
$
1.630
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.630
Open
1.610
VWAP
1.56
Vol
278.69K
Mkt Cap
15.78M
Low
1.520
Amount
434.31K
EV/EBITDA(TTM)
--
Total Shares
69.11M
EV
14.87M
EV/OCF(TTM)
--
P/S(TTM)
0.14
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
9.34M
+44.71%
-1.105
-3.91%
8.36M
+2.39%
-1.795
-76.78%
6.91M
+13.72%
-2.075
-93.35%
Estimates Revision
The market is revising Upward the revenue expectations for Bionano Genomics, Inc. (BNGO) for FY2025, with the revenue forecasts being adjusted by 0.85% over the past three months. During the same period, the stock price has changed by -44.37%.
Revenue Estimates for FY2025
Revise Upward
+0.85%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+10.75%
In Past 3 Month
Stock Price
Go Down
-44.37%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast BNGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BNGO is 9.50 USD with a low forecast of 8.00 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 1.630
Low
8.00
Averages
9.50
High
11.00
Current: 1.630
Low
8.00
Averages
9.50
High
11.00
H.C. Wainwright
Buy
maintain
$10 -> $11
2025-08-18
Reason
H.C. Wainwright
Price Target
$10 -> $11
2025-08-18
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Bionano Genomics to $11 from $10 and keeps a Buy rating on the shares. The company demonstrated sequential revenue growth in Q2, the analyst tells investors in a research note.
Maxim
Jason McCarthy
Hold
to
Buy
upgrade
$8
2025-05-20
Reason
Maxim
Jason McCarthy
Price Target
$8
2025-05-20
upgrade
Hold
to
Buy
Reason
Maxim analyst Jason McCarthy upgraded Bionano Genomics to Buy from Hold with an $8 price target. The company has taken several steps to get itself back on track, including significant cost reductions, refocusing on its core optical genome mapping business, shifting focus from customer acquisition to expanding utilization, and securing cash runway into Q1 of FY26, the analyst tells investors in a research note. Optical genome mapping is also gaining traction at leading institutions, seeing real-world use, and generating publications, the firm adds.
HC Wainwright & Co.
Yi Chen
Strong Buy
Initiates
$10
2025-04-09
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$10
2025-04-09
Initiates
Strong Buy
Reason
Scotiabank
Sung Ji Nam
Hold
Maintains
$1 → $4
2025-04-02
Reason
Scotiabank
Sung Ji Nam
Price Target
$1 → $4
2025-04-02
Maintains
Hold
Reason
Ladenburg Thalmann
Jeff Cohen
Strong Buy
to
Hold
Downgrades
n/a
2024-11-15
Reason
Ladenburg Thalmann
Jeff Cohen
Price Target
n/a
2024-11-15
Downgrades
Strong Buy
to
Hold
Reason
Ladenburg analyst Jeffrey Cohen downgraded Bionano Genomics to Neutral from Buy.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Bionano Genomics Inc (BNGO.O) is -0.27, compared to its 5-year average forward P/E of -6.83. For a more detailed relative valuation and DCF analysis to assess Bionano Genomics Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-6.83
Current PE
-0.27
Overvalued PE
3.53
Undervalued PE
-17.18
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-6.58
Current EV/EBITDA
-1.26
Overvalued EV/EBITDA
5.14
Undervalued EV/EBITDA
-18.31
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
23.49
Current PS
1.63
Overvalued PS
62.08
Undervalued PS
-15.11
Financials
Annual
Quarterly
FY2025Q2
YoY :
-13.36%
6.73M
Total Revenue
FY2025Q2
YoY :
-50.64%
-7.80M
Operating Profit
FY2025Q2
YoY :
-57.74%
-6.86M
Net Income after Tax
FY2025Q2
YoY :
-86.18%
-1.99
EPS - Diluted
FY2025Q2
YoY :
-83.44%
-3.49M
Free Cash Flow
FY2025Q2
YoY :
+55.26%
51.64
Gross Profit Margin - %
FY2025Q2
YoY :
-67.24%
-95.03
FCF Margin - %
FY2025Q2
YoY :
-51.22%
-101.84
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
BNGO News & Events
Events Timeline
2025-11-06 (ET)
2025-11-06
08:25:40
Bionano Genomics Reveals Study Findings on OGM Publication
2025-09-16 (ET)
2025-09-16
09:11:25
Bionano Genomics sets public offering price at $2.00 for 5 million shares
2025-09-16
07:08:20
Bionano Genomics Releases Book Series on OGM in Chromoanagenesis Research
Sign Up For More Events
Sign Up For More Events
News
8.5
09-21Yahoo FinanceBionano Genomics Initiates $10 Million Public Offering
8.5
09-17NewsfilterBionano Genomics, Inc. Completes $10 Million Public Offering
8.5
09-17NASDAQ.COMBiotech Stocks Surge After Hours Due to Trial Advancements, Funding Developments, and Anticipated Milestones
Sign Up For More News
People Also Watch
MCO
Moody's Corp
487.980
USD
+1.20%
PPC
Pilgrims Pride Corp
37.050
USD
+1.20%
PAY
Paymentus Holdings Inc
37.460
USD
+3.65%
STX
Seagate Technology Holdings PLC
279.350
USD
+0.32%
SNAP
Snap Inc
8.210
USD
+2.50%
SNT
Senstar Technologies Corp
4.460
USD
-1.11%
FUN
Six Flags Entertainment Corp
18.030
USD
-1.96%
AMP
Ameriprise Financial Inc
461.430
USD
+0.85%
EXP
Eagle Materials Inc
206.960
USD
+0.69%
GAME
GameSquare Holdings Inc
0.572
USD
+7.33%
FAQ
What is Bionano Genomics Inc (BNGO) stock price today?
The current price of BNGO is 1.63 USD — it has increased 1.24 % in the last trading day.
What is Bionano Genomics Inc (BNGO)'s business?
What is the price predicton of BNGO Stock?
What is Bionano Genomics Inc (BNGO)'s revenue for the last quarter?
What is Bionano Genomics Inc (BNGO)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Bionano Genomics Inc (BNGO)'s fundamentals?
How many employees does Bionano Genomics Inc (BNGO). have?
